FDA Approves Genentech’s Lucentis (ranibizumab) for all Forms of Diabetic Retinopathy

Article Link: FDA Approves Genentech’s Lucentis (ranibizumab) for all Forms of Diabetic Retinopathy



Source: FDA New Drug Approvals